African American Cancer Clinical Trial Decisions: Testing Tailored Messages



Status:Recruiting
Conditions:Blood Cancer, Blood Cancer, Lymphoma, Leukemia
Therapuetic Areas:Oncology
Healthy:No
Age Range:21 - Any
Updated:5/9/2018
Start Date:May 1, 2015
End Date:December 20, 2019
Contact:Richard Brown, Ph.D.
Email:rbrown39@vcu.edu
Phone:804-628-3340

Use our guide to learn which trials are right for you!

The purpose of this study is to determine if the use of tailored health messages and/or
involving physicians are effective in increasing African American (AA) patient activation in
a clinical trial consultation. The proposal will use a composite score for patient activation
derived from the Street Patient Activation Coding system. This will help to determine the
effectiveness of our intervention on patient activation and patient centered clinical trial
decision.

A randomized clinical trial (using a 2x2 factorial design) to inform our knowledge of the
efficacy of a tailored health message intervention, using different depths of tailoring and
involving physicians, on AA cancer patients' active communication in CT consultations as
measured by the Street Patient Activation measure. In this study 357 AA cancer patients will
be randomized into one of four experimental groups Group 1 - messages tailored on Electronic
Medical Record (EMR) data. Group 2 - messages tailored on EMR + physician involvement. Group
3 - messages tailored on EMR + survey. Group 4 - Messages tailored on EMR + survey +
physician involvement. We will also measure patient: a) trust in their physician, b) trust in
medical research, c) preferences that include information and decision involvement, d)
communication self-efficacy, e) patient-family member communication congruence, f)
consultation satisfaction and g) decision outcomes that include decisional conflict, decision
satisfaction and decision regret.

Inclusion:

- 21 years of age or older

- Have a cancer diagnosis

- Self identify as African American

- Therapeutic Phase I, II or III clinical trial at Massey Cancer Center (regardless of
whether or not they join the therapeutic trial)

- Be able to provide informed consent

- We will also recruit one family member/caregiver (N = 357) of each participating
patient

- Consented patients will not be excluded from this study if their family member
declines to participate by completing the Cancer Communication Assessment Tool for
Families (CCAT-F).
We found this trial at
1
site
401 College Street
Richmond, Virginia 23298
(804) 828-0450
Principal Investigator: Richard Brown, PhD
Phone: 804-628-3340
Virginia Commonwealth University Massey Cancer Center Founded in 1974, VCU Massey Cancer Center is a...
?
mi
from
Richmond, VA
Click here to add this to my saved trials